An inventory-location optimization model for equitable influenza vaccine distribution in developing countries during the COVID-19 pandemic
M. Rastegar, M. Tavana, A. Meraj, H. Mina, Vaccine 39 (2021) 495–504.
Download
No fulltext has been uploaded.
Journal Article
| Published
| English
Author
Rastegar, Mehdi;
Tavana, MadjidLibreCat;
Meraj, Afshin;
Mina, Hassan
Publishing Year
Journal Title
Vaccine
Volume
39
Issue
3
Page
495-504
ISSN
LibreCat-ID
Cite this
Rastegar M, Tavana M, Meraj A, Mina H. An inventory-location optimization model for equitable influenza vaccine distribution in developing countries during the COVID-19 pandemic. Vaccine. 2021;39(3):495-504. doi:10.1016/j.vaccine.2020.12.022
Rastegar, M., Tavana, M., Meraj, A., & Mina, H. (2021). An inventory-location optimization model for equitable influenza vaccine distribution in developing countries during the COVID-19 pandemic. Vaccine, 39(3), 495–504. https://doi.org/10.1016/j.vaccine.2020.12.022
@article{Rastegar_Tavana_Meraj_Mina_2021, title={An inventory-location optimization model for equitable influenza vaccine distribution in developing countries during the COVID-19 pandemic}, volume={39}, DOI={10.1016/j.vaccine.2020.12.022}, number={3}, journal={Vaccine}, publisher={Elsevier BV}, author={Rastegar, Mehdi and Tavana, Madjid and Meraj, Afshin and Mina, Hassan}, year={2021}, pages={495–504} }
Rastegar, Mehdi, Madjid Tavana, Afshin Meraj, and Hassan Mina. “An Inventory-Location Optimization Model for Equitable Influenza Vaccine Distribution in Developing Countries during the COVID-19 Pandemic.” Vaccine 39, no. 3 (2021): 495–504. https://doi.org/10.1016/j.vaccine.2020.12.022.
M. Rastegar, M. Tavana, A. Meraj, and H. Mina, “An inventory-location optimization model for equitable influenza vaccine distribution in developing countries during the COVID-19 pandemic,” Vaccine, vol. 39, no. 3, pp. 495–504, 2021, doi: 10.1016/j.vaccine.2020.12.022.
Rastegar, Mehdi, et al. “An Inventory-Location Optimization Model for Equitable Influenza Vaccine Distribution in Developing Countries during the COVID-19 Pandemic.” Vaccine, vol. 39, no. 3, Elsevier BV, 2021, pp. 495–504, doi:10.1016/j.vaccine.2020.12.022.